SEARCH RESULTS FOR: "Tag: IMMU"
REFINE YOUR SEARCH:
RECENT
Last Month(2)
ARTICLES/BLOGS
2020(2)
2019(7)
2018(4)
2017(2)
2015(1)
CATEGORIES
Analyst Update(1)
Buzz Stocks(7)
Editor's Pick(2)
Intraday Option Activity(3)
Midday Market Check(1)
Opening View(1)
Quantitative Analysis(6)
Stocks On the Move(1)
Technical Analysis(1)

9/14/2020 1:55 PM
A number of announcements regarding buyout offers for the entirety of -- or at least a large stake in -- various companies is kicking the week off at a rapid pace today. Specifically, biotech Immunome...
9/14/2020 11:55 AM
It's been a whirlwind start to the week, with dealmaking dominating the headlines. One of the more notable is Gilead Sciences, Inc. (NASDAQ:GILD) and their acquisition of Immunomedics (IMMU) for $21 b...
12/27/2019 9:51 AM
Immunomedics, Inc (NASDAQ:IMMU) is climbing towards another annual closing high today, up 2.3% at $22.16, after H.C. Wainwright lifted its price target to $31 from $26. This bull note come right on th...
12/10/2019 2:30 PM
It's been a hot start to December for Immunomedics, Inc. (NASDAQ:IMMU). The pharmaceutical stock is up 11.5% already this month, and earlier today nabbed a fresh annual high of $21.49. Heading into t...
9/30/2019 11:56 AM
One of the worst stocks on the Nasdaq today is Immunomedics, Inc. (NASDAQ:IMMU), after the company said it was delaying the submission of its application for Food and Drug Administration (FDA) approv...